News Sentiment

LAB sentiment intelligence

Standard Biotools Inc news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.

Chart Weekly report Factors RSS feed
Weighted score 53 Balanced news tone 54 relevant articles
Exchange NASDAQ United States
Sector Healthcare Market context
Industry Medical Devices Read-through group
Latest close 0.92 Week of 10 Jul 2026
Weighted tone 53/100

Balanced news tone

Market reaction Balanced read

News tone and price action are not far from neutral.

Primary event Market update

71/100 classification confidence.

Company focus 43

directly relevant articles

Source quality 2

high-authority source matches

Trend context Trend inactive

+0.6% over one week, +3.5% over four weeks, trend inactive, and below fair value.

Latest direct headline Neutral

Price to book forward of Standard BioTools Inc. – NASDAQ:LAB

Market Reaction

Balanced read

48/100 confidence

News tone and price action are not far from neutral.

Primary event Market update 71/100 classification
One-week reaction 0.6% Price digesting
Trend fit Trend inactive 3.5% over four weeks
Fair value -46.3% Below fair value
Value support

Sentiment Mix

Positive, neutral, negative

Weighted by relevance
Positive 9
Neutral 41
Negative 4

Relevance

Why the article matched

Direct first
Direct company coverage 43
Industry context 11
Sector context 0

Sources

Coverage mix

Publishers
Stock Titan 14
Market source 11
TradingView 6
GlobeNewswire 3
Minichart 2
StockStory 2
simplywall.st 2
Investing.com Australia 1

Event Lens

What the news is about

Classified themes
Earnings 17
Market update 17
Deals and strategy 16
Balance sheet 2
Regulatory and legal 1
Capital return 1

Sentiment Trail

Score over time

50 baseline
Above 50 Neutral zone Below 50

News Tape

Relevant headlines

Showing 31-54 of 54
Minichart Direct company coverage

Standard BioTools Inc. 8-K Filing Details for June 5, 2026: Company Information, NASDAQ Listing, and Legal Disclosures

Standard BioTools Inc. (NASDAQ: LAB) has regained compliance with Nasdaq's minimum bid price requirement, as confirmed by a June 5, 2026 letter from the Nasdaq Listing Qualifications Department. This resolution alleviates previous non-compliance issues from an April 20, 2026 noti

Tone
Positive 75/100
Event
Market update
Published
06 Jun 2026 19:00
Source
Minichart
Stock Titan Direct company coverage

Standard BioTools (NASDAQ: LAB) back in compliance with Nasdaq bid rule

Standard BioTools Inc. (NASDAQ: LAB) has regained compliance with Nasdaq's minimum bid price rule, as confirmed by Nasdaq on June 5, 2026. This resolves a prior notice from April 20, 2026, when the company's stock fell below $1.00 per share for 30 consecutive business days. Maint

Tone
Positive 66/100
Event
Market update
Published
06 Jun 2026 03:40
Source
Stock Titan
TradingView Direct company coverage

Standard BioTools regains Nasdaq bid-price compliance; matter closed

Standard BioTools (LAB) has regained compliance with Nasdaq's $1.00 bid-price rule, officially closing the deficiency matter. The company received notification from Nasdaq on June 5, 2026, confirming its compliance after being previously flagged on April 20, 2026, when its closin

Tone
Positive 71/100
Event
Market update
Published
05 Jun 2026 20:40
Source
TradingView